Chicago, IL, United States of America

Sydney O Ugwu

USPTO Granted Patents = 7 

 


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Wheeling, IL (US) (2006 - 2012)
  • Gurnee, IL (US) (2010 - 2014)
  • Chicago, IL (US) (2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Sydney O Ugwu: Innovator in Pharmaceutical Formulations

Introduction

Sydney O Ugwu is a notable inventor based in Chicago, IL (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of 7 patents, he has made significant strides in developing innovative treatments, particularly in oncology.

Latest Patents

Among his latest patents is the invention titled "SYN3 compositions and methods." This patent discloses aqueous and lyophilized formulations containing SYN3, along with methods for their use in treating bladder cancer. Another significant patent is focused on "Processes of making and using pharmaceutical formulations of antineoplastic agents." This invention outlines a pharmaceutical formulation that includes at least one antineoplastic agent or a pharmaceutically acceptable salt, combined with a dissolution enhancing agent to improve solubility in aqueous diluents.

Career Highlights

Sydney has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Sydney has collaborated with esteemed colleagues, including Peter M Ihnat and Vinay Radhakrishnan. These collaborations have further enriched his work and contributed to the advancement of pharmaceutical research.

Conclusion

Sydney O Ugwu stands out as a significant figure in the realm of pharmaceutical innovations, with a focus on developing effective treatments for cancer. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…